Overview (18 Sep 2026)
Oxygenta Pharmaceutical Ltd
OXYGENTAPH
INE102E01018

Pharmaceuticals
0.2

Prev. Close
Previous Close
53
Current Close
53.2
Current High
55.28
Current Low
53
52 Week High
74
52 Week Low
43
Resistance 1
54.66
Resistance 2
56.11
Support 1
52.38
Support 2
50.10
Std Deviation
12.09%
DMA 200
53.94
DMA 50
55.19
DMA 20
56.21
Fundamentals and Ratios
Standalone
Trailing EPS
-4.75
Forwad EPS
-3.12
Trailing P/E
NA
Forward P/E
NA
PEG Ratio
-0.79
Mkt. Cap (Cr)
Market Cap (Cr)
196.75
Total Debt(Cr)
Tot. Debt(Cr)
62.23
Reserve (Cr)
-62.62
Book Value
NA
P/BV Ratio
NA
ROCE(%)
-27.00
ROE
N/A

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue3749.6133.9314.315.14112.98
Other Income0.020.170.00-0.060.170.29
Total Income37.0249.7933.9314.2515.30113.27
Interest2.461.811.390.950.634.78
Expenditure-39.53-51.07-40.26-20.68-23.40-135.45
PBDT0.000.000.000.000.000.00
Depreciation-0.620.24-0.86-0.86-0.85-2.32
PBT-2.51-1.28-6.33-6.440.00-22.18
Tax0.40-0.421.481.512.004.61
Equity0.000.000.000.000.000.00
OPM-6.78-2.58-18.65-45.010.00-20.00
Net Profit-2.51-1.7-4.84-4.93-6.11-17.57
NPM-6.78-3.43-14.27-34.47-40.34-16
EPS-0.57-0.45-1.32-1.330-4.75
Consolidated
TypeFY24-25
Revenue109.299
Other Income1.31
Total Income110.61
Interest3.61
Expenditure-124.69
PBDT0.00
Depreciation-1.78
PBT-14.35
Tax4.05
Equity36.98
OPM-12.98
Net Profit-10.3
NPM-9.31
EPS0
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings